Osteoporosis News

The rate of osteoporosis medication initiation for older adults hospitalized for hip fracture has fallen steadily during the past decade, according to an insurance claims database analysis published in JAMA Network Open.

In the year after experiencing a hip fracture, risk for death increases by 33% in men and 20% in women, with this risk continuing to persist for 10 years, according to a hospital-based registry analysis published in The Journal of Clinical Endocrinology & Metabolism.

AMSTERDAM — Patients with osteoporosis who experience a fracture are at an immediate increased risk for sustaining another within 2 to 3 years, presenting a “unique window of opportunity” for treatment, according to a presentation at the EULAR Annual Congress. “

June is Men’s Health Month, an annual commemoration intended “to heighten the awareness of preventable health problems and encourage early detection and treatment of disease among men and boys,” according to MensHealthMonth.org.

The Global Alliance for Musculoskeletal Health along with international experts are asking for health authorities to address the burden of musculoskeletal conditions, which affect one in three people internationally, according to recent research published in the Bulletin of the World Health Organization.

In an update to its 2011 recommendations, the U.S. Preventive Services Task Force recommends screening with bone measurement testing to prevent osteoporotic fractures in women aged at least 65 years and in postmenopausal, high-risk women younger than 65 years.

New research suggests that men older than 65 years with known risk factors for fractures should be screened for osteoporosis, according to findings presented at the American Geriatrics Society annual meeting.

DESTIN, Fla. — Among previously untreated patients with osteoporosis who are at high risk for fracture, proactive therapy with anabolic agents, followed by sequential monotherapy with denosumab, can minimize pharmacology exposure while maximizing benefits to bone mineral density and strength, according to findings presented at the 2018 Congress of Clinical Rheumatology.

Among postmenopausal women with osteoporosis, higher anxiety levels increased risk for bone fracture, according to findings published in Menopause.

DESTIN, Fla. —Patients with osteoporosis treated with romosozumab demonstrated substantial gains in bone mineral density and T-score increases within 1 year, with continued progress following transition to denosumab, according to findings presented at the 2018 Congress of Clinical Rheumatology.